7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Peng X et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. 2013 PLoS ONE pmid:23516466
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Silva Vde O et al. β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. 2015 PLoS ONE pmid:26291983
Gennaro G et al. Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. 2015 PLoS ONE pmid:26270535
Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. 2013 PLoS ONE pmid:24236172
Goyden J et al. The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. 2015 PLoS ONE pmid:26030441
Zhou S et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. 2013 PLoS ONE pmid:23874840
de Araújo Júnior RF et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. 2013 PLoS ONE pmid:23843954
Wulf-Johansson H et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. 2013 PLoS ONE pmid:24349233
Marano RJ et al. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. 2013 PLoS ONE pmid:23667691
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Holt V et al. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. 2014 PLoS ONE pmid:25302610
Schündeln MM et al. Impairment of bone health in pediatric patients with hemolytic anemia. 2014 PLoS ONE pmid:25299063
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Buckle CH et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. 2012 PLoS ONE pmid:22952578
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Djamiatun K et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. 2012 PLoS Negl Trop Dis pmid:22563509
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
Xu Y et al. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. 2010 Planta Med. pmid:20157877
Oliver JL et al. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. 2013 Pigment Cell Melanoma Res pmid:23490134
Jang S et al. Wogonin inhibits osteoclast formation induced by lipopolysaccharide. 2010 Phytother Res pmid:19998398
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Wang Y et al. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. Phytomedicine pmid:24854571
Bitto A et al. Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. 2011 Phytomedicine pmid:21397481
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Hsieh TP et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. 2011 Phytomedicine pmid:20554188
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Zajícková K et al. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? 2008 Physiol Res pmid:18271681
Xu M et al. Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. 2009 Photomed Laser Surg pmid:18800943
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Gradosova I et al. The role of atorvastatin in bone metabolism in male albino Wistar rats. 2011 Pharmazie pmid:21901984
Wang GF et al. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. 2006 Pharmacology pmid:16636611
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854
Treuheit MJ et al. Inverse relationship of protein concentration and aggregation. 2002 Pharm. Res. pmid:12033388
Pipes GD et al. Optimization and applications of CDAP labeling for the assignment of cysteines. 2005 Pharm. Res. pmid:16028006
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Nemec K and Schubert-Zsilavecz M [Future therapies for metabolic bone diseases. New concepts and targets]. 2001 Pharm Unserer Zeit pmid:11715689
Wang AY Vascular and other tissue calcification in peritoneal dialysis patients. 2009 Perit Dial Int pmid:19270239
Bartold PM et al. Mechanisms and control of pathologic bone loss in periodontitis. 2010 Periodontol. 2000 pmid:20403105
Nagasawa T et al. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. 2007 Periodontol. 2000 pmid:17214836
Petersson M et al. Oxytocin stimulates proliferation of human osteoblast-like cells. 2002 Peptides pmid:12126740
Honsawek S et al. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. 2009 Pediatr. Surg. Int. pmid:19184056
Vidal K et al. Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. 2004 Pediatr. Res. pmid:15155868

Table of Content